Approved in 2002, the prescription drug Zelnorm (tegaserod) is a medicine which was used for the short-term treatment of women with irritable bowel syndrome (IBS) suffering constipation as their main bowel problem (IBS-C). Unfortunately, tegaserod was linked to an increased risk of heart attack, stroke, and unstable angina. Tegaserod was removed from the United States market in 2007, and today is available only for emergency situations that are life-threatening or require hospitalization. Tegaserod may be used to relieve pain, bloating, and constipation caused by irritable bowel syndrome (IBS). On April 04, 2008, the United States Food and Drug Administration (FDA) published a web page titled, “Questions and Answers About the Voluntary Discontinuation of Zelnorm’s (tegaserod maleate) Treatment Investigational New Drug (IND).” This site provides information about this medication and under what circumstances it may be still be used. What is discouraging for patients with IBS-C is that the FDA states the following: “What other treatment options are available for patients? There is no other FDA approved drug to treat IBS-C. There are options available that could relieve some of the symptoms of IBS.”
If you live in California and have taken tegaserod and, as a result, experienced cardiac disease such as heart attack, stroke, and unstable angina, you should know that attorney and physician Paul J. Molinaro is available to answer your legal questions and help you determine whether you are entitled to compensation from the manufacturer of this drug. You can reach Paul J. Molinaro, M.D. J.D. toll free at (888)MDJDLAW. The initial consultation is also free, and if Paul determines that you have a case, and you decide to hire Paul, he will represent you on a contingent basis.